Renhe Pharmaceutical Co., Ltd.
Announcement on the Results of the Company's Share Repurchase and Changes in Share Capital
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and there are no false records, misleading statements, or major omissions.
Key Information Prompt:
Date of First Disclosure of Repurchase Plan: 2026/4/24
Repurchase Plan Implementation Period: April 24, 2026 --- April 23, 2027
Estimated Repurchase Amount: RMB 80 million — RMB 150 million
Repurchase Price Cap: RMB 8.00 per share
Repurchase Purpose: □ Reduce registered capital √ For employee stock ownership plans or equity incentives □ For converting convertible corporate bonds □ To maintain company value and shareholder interests
Actual Repurchased Shares: 17,700,050 shares
Proportion of Actual Repurchased Shares to Total Share Capital: 1.2643%
Actual Repurchase Amount: RMB 99,999,600.10
Actual Repurchase Price Range: RMB 4.86 per share — RMB 5.73 per share
Renhe Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company" or "this Company") held the seventh meeting of the tenth Board of Directors on April 22, 2026, and deliberated and approved the "Proposal on the Plan for Repurchasing Company Shares by Centralized Bidding." The Company decided to use its own funds of RMB 80 million to RMB 150 million to repurchase a portion of the public shares through centralized bidding, for subsequent implementation of equity incentives or employee stock ownership plans. The repurchase price shall not exceed RMB 8.00 per share (inclusive). The estimated number of repurchased shares is 10.00 million shares to 18.75 million shares (representing 0.71%-1.34% of the Company's current total share capital). The specific number of repurchased shares shall be subject to the actual number of shares repurchased upon the expiration of the repurchase period. The implementation period for this share repurchase shall not exceed 12 months from the date the Board of Directors approved this share repurchase plan.
On April 24, 2026, and April 28, 2026, the Company disclosed the "Announcement on the Plan for Repurchasing Company Shares" (Announcement No.: 2026-015) and the "Repurchase Report" (Announcement No.: 2026-017) respectively.
On April 29, 2026, the Company disclosed the "Announcement on the First Repurchase of Company Shares" (Announcement No.: 2026-019). For details, please refer to the Company's designated information disclosure media, "Securities Times," "Securities Daily," "China Securities Journal," and the Huizhou Information Network (www.cninfo.com.cn) company announcements.